Presymptomatic treatment for Alzheimer’s disease: feasible or fanciful? (15 Nov 2012)

Lunch Hour Lecture - Autumn 2012

Prof Nick Fox, Professor of Neurology, UCL Institute of Neurology, UCL Brain Sciences

Alzheimer’s disease affects an estimated 400,000 people in the UK – that number will double over coming decades without treatments to delay or prevent disease. We are now able to ‘see’ the earliest brain changes of Alzheimer’s disease, which can appear years before first symptoms, opening up the possibility of presymptomatic trials. With serial imaging and videos of patients and at-risk individuals this lecture considers the potential and problems for such trials.

UCL is consistently ranked as one of the world's top universities. Across all disciplines our faculties are known for their research-intensive approaches, academic excellence and engagement with global challenges. This is the basis of our world-renowned degree programmes. Visit us at www.ucl.ac.uk.